Growth Metrics

LeonaBio (LONA) Non-cash Items (2019 - 2026)

LeonaBio (LONA) reported Non-cash Items of $4.2 million for Q1 2026, down 10.3% year-over-year from $4.7 million in Q1 2025, and up 106.9% on a QoQ basis from $2.0 million in Q4 2025.

LeonaBio (LONA) has 8 years of Non-cash Items data on file, last reported at $4.2 million in Q1 2026.

  • Quarterly Non-cash Items fell 10.3% year-over-year to $4.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.2 million (down 10.3% YoY) and the FY2025 annual result came in at $601353.0, up 362.58% from the prior year.
  • Non-cash Items climbed to $4.2 million in Q1 2026 per LONA's latest filing, from $2.0 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $6.2 million in Q2 2025 and bottomed at $130000.0 in Q4 2024.
  • The 5-year median for Non-cash Items is $827000.0 (2022), against an average of $2.0 million.
  • The widest annual swing landed in 2022, when Non-cash Items slumped 94.32%; it then jumped 1461.54% in 2025.
  • Tracing LONA's Non-cash Items over 5 years: stood at $827000.0 in 2022, then tumbled by 53.2% to $387000.0 in 2023, then tumbled by 66.41% to $130000.0 in 2024, then jumped by 1461.54% to $2.0 million in 2025, then soared by 106.9% to $4.2 million in 2026.
  • Per Business Quant, the three latest LONA Non-cash Items figures stand at $4.2 million (Q1 2026), $2.0 million (Q4 2025), and $542123.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 LeonaBio 181.52 Mn 113.84 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 4.20 Mn
Mar 31, 2026 4.20 Mn
Dec 31, 2025 2.03 Mn
Dec 31, 2025 2.03 Mn
Sep 30, 2025 542,123.00
Sep 30, 2025 542,123.00
Jun 30, 2025 6.20 Mn
Jun 30, 2025 6.20 Mn
Mar 31, 2025 4.68 Mn
Mar 31, 2025 4.68 Mn
Dec 31, 2024 130,000.00
Dec 31, 2024 130,000.00
Sep 30, 2024 4.88 Mn
Sep 30, 2024 4.88 Mn
Jun 30, 2024 655,000.00
Jun 30, 2024 655,000.00
Mar 31, 2024 3.27 Mn
Mar 31, 2024 3.27 Mn
Dec 31, 2023 387,000.00
Dec 31, 2023 387,000.00
Sep 30, 2023 2.59 Mn
Sep 30, 2023 2.59 Mn
Jun 30, 2023 705,000.00
Jun 30, 2023 705,000.00
Mar 31, 2023 476,000.00
Mar 31, 2023 476,000.00
Dec 31, 2022 827,000.00
Dec 31, 2022 827,000.00
Sep 30, 2022 761,000.00
Sep 30, 2022 761,000.00
Jun 30, 2022 881,856.00
Jun 30, 2022 881,856.00
Mar 31, 2022 704,013.00
Mar 31, 2022 704,013.00
Dec 31, 2021 8.31 Mn
Dec 31, 2021 8.31 Mn
Sep 30, 2021 6.00 Mn
Sep 30, 2021 6.00 Mn
Jun 30, 2021 12.20 Mn
Jun 30, 2021 12.20 Mn
Mar 31, 2021 12.40 Mn
Mar 31, 2021 12.40 Mn
Dec 31, 2020 49.28 Mn
Dec 31, 2020 49.28 Mn
Sep 30, 2020 18.52 Mn
Sep 30, 2020 18.52 Mn
Dec 31, 2019 500,000.00
Dec 31, 2019 500,000.00